Sorted By:

Relevance


Joint BIO/PhRMA Statement on PDUFA Reauthorization

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
https://www.phrma.org/press-release/joint-bio/phrma-statement-on-pdufa-reauthorization

How modernizing FDA regulations can benefit patients, providers and payers

PhRMA  |  Blog Post

PhRMA looks forward to participating in the hearing, and we hope that the agency will act expeditiously to modernize its regulations in this important area.
http://catalyst.phrma.org/how-modernizing-fda-regulations-can-benefit-patients-providers-and-payers

Patient Profile: How Medicare Part D Extra Help Works - Mateo

PhRMA  |  Graphic

He does this with the help of his Medicare Part D prescription drug coverage. 
https://www.phrma.org/graphic/patient-profile-how-medicare-part-d-extra-help-works-mateo

Researching Alzheimer’s Medicines: Setbacks and Stepping Stones

PhRMA  |  Report

However, the path from basic research to new drug treatments is extremely long and complex with many setbacks along the way, particularly in the case of Alzheimer’s disease.
https://www.phrma.org/report/researching-alzheimer-s-medicines-setbacks-and-stepping-stones

PhRMA Statement on the FDA and NIH Workforce Authorities Modernization Act

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
https://www.phrma.org/press-release/phrma-statement-on-the-fda-and-nih-workforce-authorities-modernization-act

Legislative and Regulatory History of the Evolution of 340B Program

PhRMA  |  Fact Sheet

Learn the history of the evolution of this program.
https://www.phrma.org/fact-sheet/legislative-and-regulatory-history-of-the-evolution-of-340b-program

New Policy Solutions for Innovative Treatment Delivery

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
https://www.phrma.org/press-release/phrma-releases-new-policy-solutions-for-delivering-innovative-treatments-to-patients

4 Things to know about the QuintilesIMS Medicines Use and Spending in the U.S. report

PhRMA  |  Blog Post

But, in order to have productive conversations, we need to be using the same set of facts.
http://catalyst.phrma.org/4-things-to-know-about-the-quintilesims-medicines-use-and-spending-in-the-us-report

Biopharmaceutical Leaders: Japanese Patients, Health Care System and Economy Benefit from Access to Innovative Medicines

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org

Senior Director – Science and Regulatory Advocacy (Drug Development Tools)

PhRMA  |  PhRMA Career

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org

HIV/AIDS: Decline in Death Rates

Chartpack  |  From Our Network

The number of US AIDS deaths decreased dramatically following the introduction of highly active antiretroviral treatment.
http://chartpack.phrma.org/biophrma-chartpack/advances-in-treatment/hiv/aids-decline-in-death-rates

Collaboration Between PhRMA and Scientific American Highlights Biomedical Science

PhRMA  |  Blog Post

Fox Foundation for Parkinson’s Research Fox Trial Finder, and the day-to-day impact of disease.
http://catalyst.phrma.org/collaboration-between-phrma-and-scientific-american-highlights-biomedical-science

Who gets a seat at ICER’s table? Hint: It’s not patients

PhRMA  |  Blog Post

An organization with this goal could be useful as we move toward a personalized, value-driven health care system, but ICER seems more bent on advancing misleading claims from   pharmacy benefit managers and insurers about spending on innovative treatments and cures.
http://catalyst.phrma.org/who-gets-a-seat-at-icers-table-hint-its-not-patients

Biopharmaceutical Sector Supports Nearly 84,000 Florida Jobs

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested over $500 billion in the search for new treatments and cures, including an estimated $48.5 billion in 2012 alone.
https://www.phrma.org/press-release/biopharmaceutical-sector-supports-nearly-84-000-florida-jobs

Future Impact: Need for New Treatments for Alzheimer’s Disease

Chartpack  |  From Our Network

The development of a new treatment that delays the onset of Alzheimer’s could reduce Medicare and Medicaid spending on patients by $218 billion annually by 2050.  
http://chartpack.phrma.org/2016-perspective/chapter-1/future-impact-need-for-new-treatments-for-alzheimer-s-disease

Opening the conversation around mental health treatment with advocates & industry leaders

PhRMA  |  Blog Post

“I knew there were a lot of people just like me, and I just wanted to give them hope.”
http://catalyst.phrma.org/opening-the-conversation-around-mental-health-treatment-with-advocates-industry-leaders

Medicare Monday: Catch up on MedPAC and its Part B recommendations

PhRMA  |  Blog Post

Put Part B spending on medicines into perspective and learn the facts.
http://catalyst.phrma.org/medicare-monday-catch-up-on-medpac-and-its-part-b-recommendations

Biopharma leads sustained economic growth driven by IP-intensive industries

PhRMA  |  Blog Post

As the study demonstrates, IP-intensive industries, including the biopharmaceutical industry, help drive sustained economic growth, high-paying jobs, and investments in research & development.
http://catalyst.phrma.org/biopharma-leads-sustained-economic-growth-driven-by-ip-intensive-industries

How A Cancer Drug Has Saved People From Going Blind

From Hope To Cures  |  From Our Network

This would have been unheard of in the days before these injections.
http://www.fromhopetocures.org/how-a-cancer-drug-has-saved-people-from-going-blind

Medicare Monday: Open enrollment starts this weekend

PhRMA  |  Blog Post

And be sure to talk to your doctor about your health care needs.
http://catalyst.phrma.org/medicare-monday-open-enrollment-starts-this-weekend

Patient Profile: How Medicare Part D Extra Help Works- Diane

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/patient-profile-how-medicare-part-d-extra-help-works-diane

Exchanges Impose High Out-of-Pocket Costs on Cancer Patients

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/exchanges-impose-high-out-of-pocket-costs-on-cancer-patients

Alabama Clinical Trials Benefit Patients and the Economy

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested approximately $550 billion in the search for new treatments and cures, including an estimated $48.5 billion in 2012 alone.
https://www.phrma.org/press-release/alabama-clinical-trials-benefit-patients-and-the-economy

More than 85 medicines in development for Alzheimer’s disease

PhRMA  |  Blog Post

If a new medicine could delay the onset of Alzheimer’s disease by five years, roughly $367 billion annually in long-term care and other health care costs could be avoided by 2050.
http://catalyst.phrma.org/more-than-85-medicines-in-development-for-alzheimers-disease

High Cholesterol Patient Profile - Sheryl

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/high-cholesterol-patient-profile-sheryl

You have reviewed the first 225 results out of 2649. Each page contains 25 results. You're on page 9.

prev 7 8 9 10 11 12 next